Analysts are bullish about Viking Therapeutics. Wall Street likes the company's promising pipeline, especially lead candidate VK-2735. Aggressive investors could find Viking Therapeutics stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results